On June 12, 2017, Hayden Jeffreys, the Interim Chief Executive Officer of ERBA Diagnostics, Inc. (the company), delivered notice to the company of his intention to resign from his positions as the Interim Chief Executive Officer of the company and as a member of the company's Board of Directors, effective as of September 11, 2017. Suresh Vazirani, the Executive Chairman of the company, is working with Mr. Jeffreys during this transition period.
ERBA Diagnostics, Inc.
Equities
ERBA
US29490B1017
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |